The advances made in cancer therapy are changing the rules of the game, according to FDA’s top oncology official, and the agency stands ready for that change.
In similar comments made at an Oct. 28 briefing on the agency’s efforts in personalized medicine and at the Institute...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?